MIDDLETON FRED A
Insider CIK 1267959 · CMRX Director · ECYT Director · STXS Director · PCRX Director, 10% owner · CALC Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CALC CalciMedica, Inc. | P Buy | 2026-06-25 | 2026-06-29 | 248,972 | $0.80 | $199.2K | 1,063,272 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2025-06-24 | 2025-06-26 | 19,687 | — | $0 | 19,687 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2025-06-24 | 2025-06-26 | 6,562 | — | $0 | 6,562 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 35,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 60,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 50,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 35,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 60,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 21,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 21,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer deriv | 2025-04-21 | 2025-04-21 | 42,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer | 2025-04-21 | 2025-04-21 | 40,000 | $8.55 | $342.0K | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer | 2025-04-21 | 2025-04-21 | 2,776,093 | $8.55 | $23.74M | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer | 2025-04-21 | 2025-04-21 | 531,861 | $8.55 | $4.55M | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer | 2025-04-21 | 2025-04-21 | 207,523 | $8.55 | $1.77M | 0 | SEC↗ |
| CMRX CHIMERIX INC | D To issuer | 2025-04-21 | 2025-04-21 | 60,000 | $8.55 | $513.0K | 0 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-12-06 | 2024-12-06 | 4,800 | $2.65 | $12.7K | 36,514 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-11-01 | 2024-11-05 | 877 | $3.75 | $3.3K | 22,479 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-11-01 | 2024-11-05 | 86,867 | $3.75 | $325.8K | 814,300 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-11-01 | 2024-11-05 | 20,000 | $3.75 | $75.0K | 31,714 | SEC↗ |
| CMRX CHIMERIX INC | G Gift | 2024-10-28 | 2024-10-30 | 60,000 | — | $0 | 40,000 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2024-08-27 | 2024-08-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2024-06-20 | 2024-06-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2024-03-28 | 2024-04-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 121,678 | $0.13 | $15.8K | 121,678 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 121,678 | $0.13 | $15.8K | 121,678 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 72,338 | $0.13 | $9.4K | 72,338 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 97,236 | $0.13 | $12.6K | 97,236 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 97,236 | $0.13 | $12.6K | 97,236 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 25,516 | $0.13 | $3.3K | 25,516 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 25,516 | $0.13 | $3.3K | 25,516 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 6,592 | $0.13 | $857 | 6,592 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 6,592 | $0.13 | $857 | 6,592 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 1,960 | $0.13 | $255 | 1,960 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 1,960 | $0.13 | $255 | 1,960 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 14,372 | $0.13 | $1.9K | 14,372 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 14,372 | $0.13 | $1.9K | 14,372 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy deriv | 2024-01-23 | 2024-01-25 | 72,338 | $0.13 | $9.4K | 72,338 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-01-23 | 2024-01-25 | 28,744 | $3.70 | $106.4K | 30,292 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-01-23 | 2024-01-25 | 51,032 | $3.70 | $188.8K | 114,260 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-01-23 | 2024-01-25 | 243,356 | $3.70 | $900.4K | 946,744 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-01-23 | 2024-01-25 | 3,920 | $3.70 | $14.5K | 21,602 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-01-23 | 2024-01-25 | 13,184 | $3.70 | $48.8K | 27,609 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-01-23 | 2024-01-25 | 194,472 | $3.70 | $719.5K | 435,148 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-01-23 | 2024-01-25 | 144,676 | $3.70 | $535.3K | 727,433 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2023-11-17 | 2023-11-20 | 17,295 | $0.96 | $16.6K | 100,000 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2023-11-10 | 2023-11-13 | 2,705 | $0.92 | $2.5K | 82,705 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2023-09-25 | 2023-09-26 | 20,000 | $0.98 | $19.6K | 80,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2023-06-09 | 2023-06-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-06-09 | 2023-06-09 | 714 | $5.20 | $3.7K | 11,714 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-06-07 | 2023-06-08 | 500 | $5.20 | $2.6K | 11,000 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-06-06 | 2023-06-08 | 500 | $4.88 | $2.4K | 10,500 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-19 | 2023-05-22 | 10,000 | $2.85 | $28.5K | 10,000 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-05-08 | 2023-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2023-03-28 | 2023-03-29 | 20,000 | $1.21 | $24.2K | 60,000 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 15,403 | — | $0 | 15,403 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 6,852 | — | $0 | 6,852 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 1,910 | — | $0 | 1,910 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 2,685 | — | $0 | 2,685 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 16,539 | — | $0 | 16,539 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 2,672 | — | $0 | 2,672 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 167 | — | $0 | 167 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 237 | — | $0 | 237 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 183 | — | $0 | 183 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 8,393 | — | $0 | 8,393 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 12,380 | — | $0 | 12,380 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 2,203 | — | $0 | 2,203 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 3,249 | — | $0 | 3,249 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 569 | — | $0 | 569 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 840 | — | $0 | 840 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 113 | — | $0 | 113 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award deriv | 2023-03-20 | 2023-03-22 | 5,760 | — | $0 | 5,760 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 8,884 | — | $0 | 8,884 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 1,548 | — | $0 | 1,548 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 47,052 | — | $0 | 47,052 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 14,425 | — | $0 | 14,425 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 256,852 | — | $0 | 256,852 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 8,176 | — | $0 | 8,176 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 7,456 | — | $0 | 7,456 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 17,682 | — | $0 | 17,682 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 582,757 | — | $0 | 582,757 | SEC↗ |
| CALC CalciMedica, Inc. /DE/ | A Award | 2023-03-20 | 2023-03-22 | 703,388 | — | $0 | 703,388 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2022-09-29 | 2022-10-03 | 20,000 | $1.86 | $37.2K | 40,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2022-06-23 | 2022-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2022-05-19 | 2022-05-20 | 20,000 | $2.04 | $40.8K | 20,000 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2021-06-28 | 2021-06-29 | 6,950 | $7.83 | $54.4K | 207,523 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2021-06-25 | 2021-06-29 | 3,050 | $7.78 | $23.7K | 200,573 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2021-06-23 | 2021-06-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2020-06-11 | 2020-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2020-03-12 | 2020-03-16 | 50,000 | $1.40 | $70.0K | 197,523 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2019-11-13 | 2019-11-13 | 30,000 | $1.82 | $54.6K | 147,523 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2019-11-11 | 2019-11-13 | 20,000 | $1.66 | $33.2K | 117,523 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2019-06-20 | 2019-06-24 | 21,000 | — | $0 | 21,000 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2019-05-10 | 2019-05-13 | 30,000 | $2.92 | $87.6K | 97,523 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $21.73 | $423.7K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $17.98 | $242.7K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $20.65 | $278.8K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $17.31 | $242.3K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $11.06 | $154.8K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 10,000 | $17.57 | $175.7K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 10,000 | $12.20 | $122.0K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 15,706 | $18.00 | $282.7K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 110,189 | $24.00 | $2.64M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 100,828 | $24.00 | $2.42M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 113,315 | $24.00 | $2.72M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 904,465 | $24.00 | $21.71M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 1,017,304 | $24.00 | $24.42M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 1,212,413 | $24.00 | $29.10M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 267,491 | $24.00 | $6.42M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 249,148 | $24.00 | $5.98M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 162,170 | $24.00 | $3.89M | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 8,434 | $24.00 | $202.4K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 10,049 | $24.00 | $241.2K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | G Gift | 2018-12-11 | 2018-12-21 | 83,860 | — | $0 | 113,489 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2018-06-20 | 2018-06-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2018-05-03 | 2018-05-04 | 19,500 | — | $0 | 19,500 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2018-05-03 | 2018-05-04 | 3,300 | — | $0 | 197,349 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2018-03-28 | 2018-03-30 | 42,000 | — | $0 | 42,000 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise deriv | 2018-03-02 | 2018-03-05 | 153,846 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise | 2018-03-02 | 2018-03-05 | 153,846 | $0.28 | $43.1K | 303,528 | SEC↗ |
| STXS Stereotaxis, Inc. | D To issuer deriv | 2018-03-01 | 2018-03-05 | 153,846 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | A Award deriv | 2018-03-01 | 2018-03-05 | 153,846 | — | $0 | 153,846 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2018-02-28 | 2018-03-01 | 380,952 | $4.20 | $1.60M | 1,212,413 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2018-02-28 | 2018-03-01 | 119,048 | $4.20 | $500.0K | 904,465 | SEC↗ |
| STXS Stereotaxis, Inc. | A Award | 2018-01-02 | 2018-01-02 | 30,000 | — | $0 | 149,682 | SEC↗ |
| STXS Stereotaxis, Inc. | A Award | 2017-07-03 | 2017-07-06 | 30,000 | — | $0 | 119,682 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2017-05-04 | 2017-05-05 | 19,500 | — | $0 | 19,500 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2017-05-04 | 2017-05-05 | 3,300 | — | $0 | 194,049 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2016-09-29 | 2016-10-03 | 153,846 | — | $0 | 153,846 | SEC↗ |
| STXS Stereotaxis, Inc. | P Buy deriv | 2016-09-29 | 2016-10-03 | 100 | $1000.00 | $100.0K | 100 | SEC↗ |
| STXS Stereotaxis, Inc. | A Award | 2016-05-24 | 2016-05-25 | 10,000 | — | $0 | 56,810 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2016-05-05 | 2016-05-06 | 13,500 | — | $0 | 13,500 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2016-05-05 | 2016-05-06 | 2,250 | — | $0 | 203,249 | SEC↗ |
| ECYT ENDOCYTE INC | P Buy | 2016-01-19 | 2016-01-20 | 10,000 | $2.79 | $27.9K | 200,999 | SEC↗ |
| ECYT ENDOCYTE INC | P Buy | 2016-01-15 | 2016-01-20 | 20,000 | $2.80 | $56.0K | 190,999 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2015-06-15 | 2015-06-16 | 26,064 | $1.57 | $40.9K | 1,107,189 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2015-06-12 | 2015-06-12 | 1,116 | $1.60 | $1.8K | 1,133,253 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2015-06-11 | 2015-06-12 | 11,703 | $1.61 | $18.8K | 1,134,369 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2015-06-10 | 2015-06-12 | 3,454 | $1.60 | $5.5K | 1,146,072 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2015-06-09 | 2015-06-09 | 13,280 | $1.60 | $21.2K | 1,149,526 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2015-06-08 | 2015-06-09 | 38,120 | $1.60 | $61.0K | 1,162,806 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2015-06-05 | 2015-06-09 | 55,476 | $1.69 | $93.8K | 1,200,926 | SEC↗ |
| STXS Stereotaxis, Inc. | A Award | 2015-06-02 | 2015-06-03 | 10,000 | — | $0 | 46,810 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2015-05-14 | 2015-05-18 | 13,500 | — | $0 | 13,500 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2015-05-14 | 2015-05-18 | 2,250 | — | $0 | 170,999 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2014-12-09 | 2014-12-09 | 7,951 | $1.51 | $12.0K | 36,810 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2014-12-05 | 2014-12-09 | 600 | $1.50 | $900 | 44,761 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2014-12-03 | 2014-12-04 | 5,809 | $1.58 | $9.2K | 45,361 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2014-12-02 | 2014-12-04 | 10,000 | $1.60 | $16.0K | 51,170 | SEC↗ |
| STXS Stereotaxis, Inc. | A Award | 2014-06-10 | 2014-06-11 | 10,000 | — | $0 | 61,170 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2014-05-15 | 2014-05-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2014-03-13 | 2014-03-17 | 3,576 | $4.28 | $15.3K | 51,170 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2014-03-13 | 2014-03-17 | 20,726 | $4.20 | $87.0K | 54,746 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 9 | $0.14 | $1 | 304 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 229 | $0.14 | $32 | 7,919 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 273 | $0.14 | $38 | 9,434 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 38,256 | $0.14 | $5.4K | 1,323,537 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 2 | $0.14 | $0 | 77 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 1,070 | $0.14 | $150 | 37,030 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 299 | $0.14 | $42 | 10,346 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 322 | $0.14 | $45 | 11,148 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 1,827 | $0.14 | $256 | 63,203 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 1,436 | $0.14 | $201 | 49,671 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 605 | $0.14 | $85 | 20,932 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 2,849 | $0.14 | $399 | 98,253 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-21 | 2013-11-22 | 12,502 | $0.14 | $1.8K | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-20 | 2013-11-22 | 16,080 | $0.10 | $1.6K | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-18 | 2013-11-20 | 20,900 | $0.22 | $4.6K | 16,080 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-15 | 2013-11-18 | 9,702 | $0.20 | $1.9K | 36,980 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 9 | $0.25 | $2 | 313 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 247 | $0.25 | $62 | 8,148 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 295 | $0.25 | $74 | 9,707 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 41,332 | $0.25 | $10.3K | 1,361,793 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 2 | $0.25 | $1 | 79 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 1,156 | $0.25 | $289 | 38,100 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 323 | $0.25 | $81 | 10,645 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 348 | $0.25 | $87 | 11,470 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 1,975 | $0.25 | $494 | 65,030 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 1,551 | $0.25 | $388 | 51,107 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 654 | $0.25 | $164 | 21,537 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 1,417 | $0.25 | $354 | 46,682 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-14 | 2013-11-18 | 3,307 | $0.25 | $827 | 101,102 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 1 | $0.28 | $0 | 81 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 1,315 | $0.28 | $368 | 104,409 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 4 | $0.28 | $1 | 322 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 98 | $0.28 | $27 | 8,395 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 117 | $0.28 | $33 | 10,002 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 16,440 | $0.28 | $4.6K | 1,403,125 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 617 | $0.28 | $173 | 52,658 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 460 | $0.28 | $129 | 39,256 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 129 | $0.28 | $36 | 10,968 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 138 | $0.28 | $39 | 11,818 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 785 | $0.28 | $220 | 67,005 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 563 | $0.28 | $158 | 48,099 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale deriv | 2013-11-13 | 2013-11-15 | 260 | $0.28 | $73 | 22,191 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-23 | 2013-08-27 | 12,200 | $3.67 | $44.8K | 75,872 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-23 | 2013-08-27 | 2,000 | $3.67 | $7.3K | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-23 | 2013-08-27 | 400 | $3.68 | $1.5K | 75,472 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-13 | 2013-08-15 | 26,506 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-13 | 2013-08-15 | 624,113 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-13 | 2013-08-15 | 328,475 | $6.39 | $2.10M | 1,256,402 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-13 | 2013-08-15 | 26,506 | $3.36 | $89.1K | 54,623 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-13 | 2013-08-15 | 13,950 | $6.39 | $89.1K | 40,673 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-13 | 2013-08-15 | 624,113 | $3.36 | $2.10M | 1,584,877 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise deriv | 2013-08-07 | 2013-08-09 | 3,455 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise deriv | 2013-08-07 | 2013-08-09 | 29,248 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise deriv | 2013-08-07 | 2013-08-09 | 149,849 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise deriv | 2013-08-07 | 2013-08-09 | 75,759 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise deriv | 2013-08-07 | 2013-08-09 | 675 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise deriv | 2013-08-07 | 2013-08-09 | 566 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise deriv | 2013-08-07 | 2013-08-09 | 2,900 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-07 | 2013-08-12 | 149,849 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-07 | 2013-08-12 | 29,248 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-07 | 2013-08-12 | 75,759 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-07 | 2013-08-12 | 675 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-07 | 2013-08-12 | 3,455 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-07 | 2013-08-12 | 566 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise deriv | 2013-08-07 | 2013-08-12 | 2,900 | — | $0 | 0 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise | 2013-08-07 | 2013-08-09 | 2,900 | $3.36 | $9.7K | 6,297 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-07 | 2013-08-09 | 962 | $10.13 | $9.7K | 5,335 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-07 | 2013-08-09 | 229 | $10.13 | $2.3K | 3,397 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise | 2013-08-07 | 2013-08-09 | 566 | $4.10 | $2.3K | 3,626 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-07 | 2013-08-09 | 1,146 | $10.13 | $11.6K | 6,358 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise | 2013-08-07 | 2013-08-09 | 3,455 | $3.36 | $11.6K | 7,504 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-07 | 2013-08-09 | 273 | $10.13 | $2.8K | 4,049 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise | 2013-08-07 | 2013-08-09 | 29,248 | $4.10 | $119.9K | 811,520 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-07 | 2013-08-09 | 11,838 | $10.13 | $119.9K | 799,682 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise | 2013-08-07 | 2013-08-09 | 149,849 | $3.36 | $503.5K | 949,531 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-07 | 2013-08-09 | 49,718 | $10.13 | $503.6K | 899,813 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise | 2013-08-07 | 2013-08-09 | 75,759 | $1.98 | $150.0K | 975,572 | SEC↗ |
| STXS Stereotaxis, Inc. | S Sale | 2013-08-07 | 2013-08-09 | 14,808 | $10.13 | $150.0K | 960,764 | SEC↗ |
| STXS Stereotaxis, Inc. | X Exercise | 2013-08-07 | 2013-08-09 | 675 | $4.10 | $2.8K | 4,322 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-07 | 2013-08-12 | 566 | $4.10 | $2.3K | 3,626 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-07 | 2013-08-12 | 14,808 | $10.13 | $150.0K | 960,764 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-07 | 2013-08-12 | 675 | $4.10 | $2.8K | 4,322 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-07 | 2013-08-12 | 11,838 | $10.13 | $119.9K | 799,682 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-07 | 2013-08-12 | 29,248 | $4.10 | $119.9K | 811,520 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-07 | 2013-08-12 | 75,759 | $1.98 | $150.0K | 975,572 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-07 | 2013-08-12 | 49,718 | $10.13 | $503.6K | 899,813 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-07 | 2013-08-12 | 962 | $10.13 | $9.7K | 5,335 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-07 | 2013-08-12 | 2,900 | $3.36 | $9.7K | 6,297 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-07 | 2013-08-12 | 229 | $10.13 | $2.3K | 3,397 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-07 | 2013-08-12 | 149,849 | $3.36 | $503.5K | 949,531 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-07 | 2013-08-12 | 1,146 | $10.13 | $11.6K | 6,358 | SEC↗ |
| STXS Stereotaxis, Inc. | M Exercise | 2013-08-07 | 2013-08-12 | 3,455 | $3.36 | $11.6K | 7,504 | SEC↗ |
| STXS Stereotaxis, Inc. | F Tax w/h | 2013-08-07 | 2013-08-12 | 273 | $10.13 | $2.8K | 4,049 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2013-07-31 | 2013-08-02 | 9,542 | — | $0 | 9,542 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2013-06-28 | 2013-08-02 | 32,258 | — | $0 | 32,258 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-24 | 2013-06-25 | 5,900 | $28.70 | $169.3K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-21 | 2013-06-25 | 28,576 | $29.22 | $835.0K | 2,222 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-21 | 2013-06-25 | 2,222 | $28.49 | $63.3K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-21 | 2013-06-25 | 36,374 | $29.22 | $1.06M | 8,728 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-21 | 2013-06-25 | 2,828 | $28.49 | $80.6K | 5,900 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-20 | 2013-06-20 | 66,100 | $28.93 | $1.91M | 30,798 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2013-06-19 | 2013-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-19 | 2013-06-20 | 48,400 | $29.76 | $1.44M | 96,898 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-18 | 2013-06-20 | 29,600 | $29.48 | $872.6K | 145,298 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2013-06-12 | 2013-06-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| STXS Stereotaxis, Inc. | A Award | 2013-06-05 | 2013-06-07 | 12,000 | — | $0 | 88,072 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-06-05 | 2013-06-07 | 241,185 | — | $0 | 174,898 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-06-05 | 2013-06-07 | 7,433 | — | $0 | 70,399 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-06-05 | 2013-06-07 | 316,660 | — | $0 | 45,102 | SEC↗ |
| STXS Stereotaxis, Inc. | J Other deriv | 2013-03-29 | 2013-04-02 | 75,758 | — | $0 | 75,758 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-19 | 2013-03-20 | 46,339 | $26.95 | $1.25M | 416,083 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-19 | 2013-03-20 | 38,250 | $27.66 | $1.06M | 462,422 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 28,956 | $29.20 | $845.5K | 530,497 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 23,969 | $29.20 | $699.9K | 24,688 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 28,558 | $29.20 | $833.9K | 29,415 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 29,825 | $28.19 | $840.8K | 500,672 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 24,688 | $28.19 | $696.0K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 29,415 | $28.19 | $829.2K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-03-15 | 2013-03-20 | 200,000 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-03-15 | 2013-03-20 | 25,133 | — | $0 | 67,966 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-11 | 2013-04-15 | 348,951 | $27.86 | $9.72M | 559,453 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 843 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 629 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 750 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 17,839 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 20,220 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 708 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 20,069 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 17,973 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 368 | $25.92 | $9.5K | 48,657 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 10,485 | $25.92 | $271.8K | 908,404 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 438 | $25.92 | $11.4K | 57,973 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 10,407 | $25.92 | $269.7K | 1,361,762 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 17,973 | $2.69 | $48.3K | 900,535 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 629 | $2.69 | $1.7K | 48,383 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 750 | $2.69 | $2.0K | 57,646 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 17,839 | $2.69 | $48.0K | 1,353,952 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 1,866 | $25.92 | $48.4K | 898,669 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 20,069 | $13.44 | $269.7K | 1,372,169 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 843 | $13.44 | $11.3K | 58,411 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 708 | $13.44 | $9.5K | 49,025 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 20,220 | $13.44 | $271.8K | 918,889 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 1,852 | $25.92 | $48.0K | 1,352,100 | SEC↗ |